EUVIMEDEUVIMED entdecken
Vergleichsstudie

Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023

Heather I Chen-Yost, Catherine Bammert, Wei Hao, Jonas J Heymann, Diana Murro Lin, Jonathan Marotti, Taryn Waraksa-Deutsch, Min Huang, Uma Krishnamurti, Oscar Lin, Amy Ly, Neda Moatamed und 2 weitere

Journal of the American Society of Cytopathology · 2024

DOI: 10.1016/j.jasc.2024.02.004 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Society of Cytopathology, 2024. Verfasst von Heather I Chen-Yost und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Michigan Medicine, Ann Arbor, Michigan. Electronic address: chheathe@med.umich.edu. Hauptthemen laut MEDLINE: COVID-19, Telepathology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: During the COVID-19 pandemic, the need for digital pathology tools became more urgent. However, there needs to be more knowledge of the use in cytology. We aimed to evaluate current digital cytology practices and attitudes and compare the results with a pre-COVID-19 American Society of Cytopathology (ASC) survey. MATERIALS AND METHODS: Fourteen survey questions assessing current attitudes toward digital cytology were developed from a 2016 ASC Digital Pathology Survey. Ten new survey questions were also created to evaluate telecytology use. The survey was e-mailed to ASC members over 6 weeks in 2023. RESULTS: A total of 123 individuals responded (116 in 2016). Attitudes toward digital cytology were unchanged; most participants stated digital cytology is beneficial (87% 2023 versus 90% 2016). The percentage of individuals using digital cytology was unchanged (56% in 2016 and 2023). However, telecytology for rapid onsite assessment (ROSE) is now considered the best application (55% 2023 versus 31% 2016). Forty-three institutions reported using digital and telecytology tools; 40% made implementations after 2020; most did not feel that COVID-19 affected digital cytology (56%). Telecytology for ROSE is the most common application now (78%) compared with education (30%) in 2016. Limitations for implementing digital imaging in cytology included inability to focus (38%) and expense (33%). CONCLUSIONS: General attitudes toward digital tools by the cytology community have essentially remained the same between 2016 and now. However, telecytology for ROSE is increasingly being used, which supports a need for validation and competency guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19TelepathologyHumansSurveys and QuestionnairesSARS-CoV-2Attitude of Health PersonnelSocieties, MedicalCytodiagnosisUnited StatesPandemics

Stichwörter der Autor:innen

COVID-19Digital cytologyROSESurveyTelecytology

Autor:innen und Institutionen

  • Department of Pathology, Michigan Medicine, Ann Arbor, Michigan. Electronic address: chheathe@med.umich.edu.
  • School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
  • Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medicine, New York, New York.
  • Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.

Zitieren

APA

Chen-Yost, H. I., Bammert, C., Hao, W., Heymann, J. J., Lin, D. M., Marotti, J., Waraksa-Deutsch, T., Huang, M., Krishnamurti, U., Lin, O., Ly, A., Moatamed, N., Pantanowitz, L., & Roy-Chowdhuri, S. (2024). Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2024.02.004

Vancouver

Chen-Yost HI, Bammert C, Hao W, Heymann JJ, Lin DM, Marotti J, et al. Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. Journal of the American Society of Cytopathology. 2024. doi:10.1016/j.jasc.2024.02.004

BibTeX
@article{ChenYost2024,
  author = {Chen-Yost, Heather I and Bammert, Catherine and Hao, Wei and Heymann, Jonas J and Lin, Diana Murro and Marotti, Jonathan and Waraksa-Deutsch, Taryn and Huang, Min and Krishnamurti, Uma and Lin, Oscar and Ly, Amy and Moatamed, Neda and Pantanowitz, Liron and Roy-Chowdhuri, Sinchita},
  title = {Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023},
  journal = {Journal of the American Society of Cytopathology},
  year = {2024},
  doi = {10.1016/j.jasc.2024.02.004}
}
Kostenlos starten →